Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation
- PMID: 8912847
Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation
Abstract
pMV7-4E cells (4E-P2), which overexpress translation initiation factor eIF-4E, contain elevated levels of ornithine decarboxylase (ODC), the first and rate-limiting enzyme in polyamine biosynthesis. We have shown previously that this induction appears to be related to the transformed phenotype of these cells (L. M. Shantz and A. E. Pegg, Cancer Res., 54: 2313-2316, 1994). To test whether increased ODC activity is responsible for the transformation of 4E-P2 cells, a dominant-negative mutant of ODC was used to reduce the intracellular ODC activity in 4E-P2 cells, and the resulting phenotypic changes were examined. The mutant K69A/C360A contains mutations to alanine of two key active site residues, lysine 69 and cysteine 360, and is truncated at 425 amino acids. Combination of purified K69A/C360A and purified wild-type ODC resulted in a dose-dependent decrease in specific activity compared with wild-type ODC alone, with a 71% reduction at equimolar concentrations. This mutant was transfected into 4E-P2 cells, and stable clones that expressed the truncated K69A/ C360A were isolated. Several clones were tested for their ability to form transformed foci on a monolayer, grow in soft agar, and form tumors in nude mice. When ODC activity was reduced by 60%, the transformed phenotype of 4E-P2 cells was abolished, suggesting strongly that high ODC levels are critical to the transformation of these cells. In addition, K69A/C360A can be used to determine the ODC activity associated with transformation in both in vitro and in vivo systems.
Similar articles
-
Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.Cancer Res. 1996 Jul 15;56(14):3265-9. Cancer Res. 1996. PMID: 8764119
-
Ornithine decarboxylase induction in transformation by H-Ras and RhoA.Cancer Res. 1998 Jul 1;58(13):2748-53. Cancer Res. 1998. PMID: 9661886
-
Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation.Cancer Res. 1994 May 1;54(9):2313-6. Cancer Res. 1994. PMID: 8162572
-
Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.Amino Acids. 2007 Aug;33(2):213-23. doi: 10.1007/s00726-007-0531-2. Epub 2007 Apr 19. Amino Acids. 2007. PMID: 17443268 Review.
-
eIF-4E expression and its role in malignancies and metastases.Oncogene. 2004 Apr 19;23(18):3189-99. doi: 10.1038/sj.onc.1207545. Oncogene. 2004. PMID: 15094768 Review.
Cited by
-
Amino acids regulate expression of antizyme-1 to modulate ornithine decarboxylase activity.J Biol Chem. 2012 Feb 3;287(6):3674-90. doi: 10.1074/jbc.M111.232561. Epub 2011 Dec 7. J Biol Chem. 2012. PMID: 22157018 Free PMC article.
-
Effect of spermine synthase on the sensitivity of cells to anti-tumour agents.Biochem J. 2003 Aug 1;373(Pt 3):885-92. doi: 10.1042/BJ20030246. Biochem J. 2003. PMID: 12737625 Free PMC article.
-
Myc, Oncogenic Protein Translation, and the Role of Polyamines.Med Sci (Basel). 2018 May 25;6(2):41. doi: 10.3390/medsci6020041. Med Sci (Basel). 2018. PMID: 29799508 Free PMC article. Review.
-
Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.Cancer Res. 2015 Jan 15;75(2):250-63. doi: 10.1158/0008-5472.CAN-14-2789. Cancer Res. 2015. PMID: 25593033 Free PMC article. Review.
-
Regulation of all members of the antizyme family by antizyme inhibitor.Biochem J. 2005 Jan 1;385(Pt 1):21-8. doi: 10.1042/BJ20040547. Biochem J. 2005. PMID: 15355308 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials